XML 25 R10.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Operating activities:      
Net income $ 269,025,000 $ 222,648,000 $ 271,605,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Provision for (recovery of) credit losses 88,071,000 48,089,000 (117,087,000)
Depreciation of premises and equipment, net 17,508,000 24,152,000 15,410,000
Accretion of fees, premiums and discounts, net (27,376,000) (28,378,000) (38,257,000)
Amortization of intangible assets 15,527,000 18,401,000 10,583,000
Amortization of right of use lease asset 15,567,000 17,990,000 11,844,000
Decrease in operating lease liability (12,417,000) (16,291,000) (11,941,000)
Income from mortgage banking activities, net (4,799,000) (7,271,000) (23,216,000)
Gain on sale of securities, net 0 0 (331,000)
Loss (gain) on sale of other real estate owned and valuation adjustments, net 195,000 (221,000) (385,000)
Stock-based compensation expense 9,605,000 6,349,000 5,694,000
Unrealized gains on equity investments, net (329,000) (5,980,000) (5,141,000)
Realized (gain) loss on sale of equity investment, net (9,493,000) 0 706,000
Deferred income tax (benefit) expense (5,397,000) (4,005,000) 39,838,000
(Increase) decrease in accrued interest receivable (11,531,000) (22,151,000) 2,739,000
Increase in other assets (2,185,000) (58,852,000) (46,378,000)
Origination of loans held-for-sale (280,826,000) (527,684,000) (971,863,000)
Proceeds from sales of loans held-for-sale 198,920,000 501,186,000 991,411,000
Increase (decrease) in accrued interest payable 41,510,000 1,196,000 (714,000)
(Decrease) increase in other liabilities (60,781,000) 315,065,000 (4,807,000)
Decrease (increase) in value of bank-owned life insurance (2,053,000) (1,311,000) (1,048,000)
Increase in capitalized interest, net (1,738,000) (2,078,000) (3,014,000)
Net cash provided by operating activities 237,003,000 480,854,000 125,648,000
Investing activities:      
Purchases of investment securities held to maturity 0 (120,868,000) 0
Repayments, maturities and calls of investment securities held to maturity 72,966,000 66,186,000 20,365,000
Sale of investment securities available-for-sale 0 0 14,051,000
Purchases of investment securities available-for-sale (27,689,000) (1,218,022,000) (3,490,596,000)
Repayments of investment securities available-for-sale 354,783,000 1,015,603,000 697,480,000
Proceeds from bank-owned life insurance death benefit 3,772,000 1,437,000 0
Proceeds from bank-owned life insurance surrender 51,981,000 0 0
Net proceeds from sale of equity investments 17,946,000 0 4,899,000
Net cash (paid for) from business combinations (3,000,000) 573,745,000 0
Net (increase) decrease in loans and leases (486,819,000) (41,324,000) 1,453,471,000
Purchases of loans held for investment (313,363,000) (393,159,000) (188,076,000)
Purchases of FHLB stock (134,279,000) (51,518,000) (625,000)
Redemption of FHLB stock 142,997,000 36,207,000 323,000
Sales of assets acquired through foreclosure, net 833,000 1,964,000 2,489,000
Sale of premise and equipment 17,000 1,191,000 427,000
Investment in premises and equipment, net (6,406,000) (8,809,000) (6,576,000)
Net cash used in investing activities (326,261,000) (137,367,000) (1,492,368,000)
Financing activities:      
Net (decrease) increase in demand and saving deposits (358,115,000) (1,123,468,000) 1,760,031,000
Increase (decrease) in time deposits 681,484,000 (94,251,000) (169,871,000)
(Decrease) increase in brokered deposits (70,915,000) 61,705,000 (202,625,000)
Receipts from FHLB advances 7,195,000,000 1,873,100,000 1,000,000
Repayments of FHLB advances (7,545,000,000) (1,523,100,000) (7,623,000)
Receipts from federal funds purchased 7,713,000,000 2,730,001,000 0
Repayments of federal funds purchased (7,713,000,000) (2,730,001,000) 0
Receipts from Bank Term Funding Program 565,000,000 0 0
Distributions to noncontrolling shareholders (4,463,000) (504,000) 0
Cash dividend (36,742,000) (35,746,000) (24,242,000)
Issuance of common stock and exercise of common stock options 3,298,000 3,179,000 1,522,000
Redemption of senior and subordinated debt (30,000,000) 0 (100,000,000)
Repurchase of common shares (54,647,000) (200,083,000) (13,268,000)
Net cash provided by (used in) financing activities 344,900,000 (1,039,168,000) 1,244,924,000
Increase (decrease) in cash, cash equivalents, and restricted cash 255,642,000 (695,681,000) (121,796,000)
Cash, cash equivalents, and restricted cash at beginning of period 837,258,000 1,532,939,000 1,654,735,000
Cash, cash equivalents, and restricted cash at end of period 1,092,900,000 837,258,000 1,532,939,000
Supplemental disclosure of cash flow information:      
Cash paid for interest during the period 209,909,000 36,487,000 23,434,000
Cash paid for income taxes, net 99,136,000 58,148,000 40,691,000
Non-cash information:      
Loans transferred to other real estate owned 1,569,000 630,000 1,972,000
Loans transferred to portfolio from held-for-sale at fair value 96,312,000 97,848,000 72,621,000
Securities transferred to held-to-maturity from available-for-sale at fair value 0 931,421,000 0
Available-for-sale securities purchased, not settled 0 0 34,489,000
Receivable for bank-owned life insurance surrender proceeds 4,731,000 0 0
Receivable for bank-owned life insurance death benefit proceeds 742,000 0 0
Fair value of assets acquired, net of cash received 7,993,000 4,713,544,000 0
Fair value of liabilities assumed $ 4,993,000 $ 4,379,273,000 $ 0